Hiroaki Oda
Overview
Explore the profile of Hiroaki Oda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song Q, Guo J, Ma Y, Ou T, Zhang J, Li H, et al.
Heliyon
. 2025 Feb;
10(21):e36416.
PMID: 39975460
[This corrects the article DOI: 10.1016/j.heliyon.2023.e16401.].
2.
Song Q, Kikumoto A, Sun S, Mochizuki S, Oda H
Food Funct
. 2024 Oct;
15(20):10516-10526.
PMID: 39365248
Overconsumption of sucrose or fat is widely acknowledged as a prominent feature of unhealthy dietary patterns. Both factors commonly co-occur and are recognized as hallmarks of the Western diet, which...
3.
Nakajima S, Hanzawa F, Ikeda S, Oda H
Sci Rep
. 2024 Sep;
14(1):22644.
PMID: 39349485
Physical inactivity as well as breakfast skipping is known as risk factor for various metabolic diseases, such as obesity and type 2 diabetes. We have previously reported that a breakfast...
4.
Song Q, Kobayashi S, Kataoka Y, Oda H
Antioxidants (Basel)
. 2024 Aug;
13(8).
PMID: 39199235
Taurine can ameliorate hypercholesterolemia by facilitating cholesterol efflux and increasing cytochrome P450 7A1 (CYP7A1) without clear underlying molecular mechanisms. This study aims to elucidate the molecular action of taurine in...
5.
Fu Y, Araki Y, Saito S, Nishitani S, Nishimura N, Mochizuki S, et al.
Clin Nutr ESPEN
. 2024 Jul;
63:491-500.
PMID: 39018242
Background & Aims: Excess sucrose intake induces metabolic syndrome. In human, abnormal lipids metabolism like obesity, hyperlipidemia and fatty liver are induced. However, excess sucrose causes different phenotypes in different...
6.
Kobayashi M, Kanbe F, Ishii R, Tsubouchi H, Hirai K, Miyasaka Y, et al.
Sci Rep
. 2023 Aug;
13(1):13813.
PMID: 37620514
High serum levels of triglycerides (TG) and low levels of high-density lipoprotein cholesterol (HDL-C) increase the risk of coronary heart disease in humans. Herein, we first reported that the C3H/HeNSlc...
7.
Song Q, Guo J, Ma Y, Ou T, Zhang J, Li H, et al.
Heliyon
. 2023 Jun;
9(6):e16401.
PMID: 37274675
Taurine has been proven in many trials to alleviate the symptoms of metabolic associated fatty liver disease. Here its protective effect for hepatic steatosis and modulation of AMP-activated protein kinase...
8.
Otani H, Okada T, Saika Y, Sakagashira M, Oda H, Ito Y, et al.
J Ren Nutr
. 2023 May;
33(5):649-656.
PMID: 37178773
Objective: In subjects with chronic kidney disease (CKD), the effect of low-protein diet (LPD) is expected to alleviate uremic symptoms. However, whether LPD is effective in preventing loss of kidney...
9.
Zhao Y, Wang Z, Liu S, Xie S, Xie Y, Li R, et al.
Biomolecules
. 2023 Mar;
13(3).
PMID: 36979431
Astaxanthin is a carotenoid with excellent antioxidant activity. However, this small lipid-soluble molecule is insoluble in water and has low stability. Although this situation can be improved when astaxanthin is...
10.
Zhao Y, Liu J, Zhang S, Wang Z, Jia H, Oda H, et al.
Int J Biol Macromol
. 2022 Nov;
223(Pt A):1186-1195.
PMID: 36347379
Astaxanthin is a natural liposoluble ketocarotenoid with various biological activities. Hydrophobic astaxanthin with C symmetry can self-assembly form H-type aggregates and J-type aggregates in hydrated polar solvents. However, astaxanthin and...